-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$0.75-27.18% Downside
Spectrum Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Spectrum Pharmaceuticals, Inc.?
Spectrum Pharmaceuticals, Inc. has been rated by research analysts at Cantor Fitzgerald in the past 90 days.